.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
QuintilesIMS
Healthtrust
Argus Health
US Army
Merck
Queensland Health
Chubb
Johnson and Johnson

Generated: June 22, 2017

DrugPatentWatch Database Preview

OXALIPLATIN Drug Profile

« Back to Dashboard

Which patents cover Oxaliplatin, and what generic Oxaliplatin alternatives are available?

Oxaliplatin is a drug marketed by Actavis Totowa, Fresenius Kabi Oncol, Sandoz Inc, Hospira Worldwide, Hospira Inc, Qilu Pharm Co Ltd, Sandoz, Sun Pharma Global, Fresenius Kabi Usa, Cipla Ltd, Gland Pharma Ltd, Mylan Labs Ltd, Teva Pharms, Jiangsu Hengrui Med, Accord Hlthcare, and Luitpold Pharms Inc. and is included in twenty-three NDAs.

The generic ingredient in OXALIPLATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the oxaliplatin profile page.

Summary for Tradename: OXALIPLATIN

Patents:0
Applicants:16
NDAs:23
Suppliers / Packagers: see list16
Clinical Trials: see list1,244
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXALIPLATIN at DailyMed

Pharmacology for Tradename: OXALIPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)207474-001Mar 21, 2017APRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)091358-001Aug 7, 2012APRXNoNo► Subscribe► Subscribe
Gland Pharma Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)207385-002May 23, 2017APRXNoNo► Subscribe► Subscribe
Luitpold Pharms Inc
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)204378-002May 12, 2017APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)090030-002Jan 31, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Baxter
Fish and Richardson
QuintilesIMS
Teva
Citi
Novartis
Colorcon
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot